Improvement of coronary artery endothelial dysfunction with lipid-lowering therapy: heterogeneity of segmental response and correlation with plasma-oxidized low density lipoprotein

This publication has 30 references indexed in Scilit:

• Exercise-induced vasomotion of angiographically normal and stenotic coronary arteries improves after cholesterol-lowering drug therapy with bezafibrate
  Journal of the American College of Cardiology, 1995
• Heterogeneity of vasomotor response to acetylcholine along the human coronary artery
  Journal of the American College of Cardiology, 1995
• The Effect of Cholesterol-Lowering and Antioxidant Therapy on Endothelium-Dependent Coronary Vasomotion
  New England Journal of Medicine, 1995
• Beneficial Effects of Cholesterol-Lowering Therapy on the Coronary Endothelium in Patients with Coronary Artery Disease
  New England Journal of Medicine, 1995
• Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia.
  Circulation, 1994
• Constrictor and dilator responses to intracoronary acetylcholine in adjacent segments of the same coronary artery in patients with coronary artery disease. Endothelial function revisited.
  Circulation, 1994
• Autoantibody against oxidised LDL and progression of carotid atherosclerosis
  The Lancet, 1992
• Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
• Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1987
• Chemical evaluation of conformational differences in native and chemically modified proteins
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1966